Richard A. Heyman sold $157K of ORIC stock

Richard A. Heyman, Dir of Oric Pharmaceuticals, Inc. (ORIC), sold 13,100 shares of ORIC stock worth $157K, per an SEC Form 4 filed Jul 28, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jul 24, 2026, 4 days before it was made public.

ORIC has moved -27.1% since the trade date, from $12.10 to $8.82 (Nov 6, 2026 close).